Drug
Divarasib
Divarasib: highest development phase Phase 3, developed by Roche. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Divarasib NCT07541170 | Phase 3 | Non-small Cell Lung Cancer |
| Divarasib NCT06793215 | Phase 3 | Non-Small Cell Lung Cancer |
| Divarasib NCT06497556 | Phase 3 | Non-Small Cell Lung Cancer |
Latest
No recent events.
Follow Divarasib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.